Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
ID: 350280Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $150K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350280

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-278.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering funding through the Cancer Research Education Grants Program (NOFO PAR-23-278) to support innovative curriculum or methods development aimed at enhancing cancer research education. This program seeks to improve training in biomedical, behavioral, and clinical research related to cancer, with a focus on developing novel instructional methods and educational resources that target diverse audiences. Eligible applicants include higher education institutions and nonprofit organizations, with a maximum funding amount of $150,000 per year for a project period of up to two years. Applications will open on December 25, 2023, and must be submitted by January 7, 2027; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-278.html
    The National Institutes of Health (NIH) is issuing a funding opportunity through the Cancer Research Education Grants Program (NOFO PAR-23-278) aimed at enhancing cancer research education. This initiative focuses on curriculum or methods development for educational activities that improve training in biomedical, behavioral, and clinical research, especially related to cancer. Eligible applicants include higher education institutions and nonprofits, among others, with a maximum budget of $150,000 per year for a project period of up to two years. Applications must emphasize innovative approaches to cancer education, targeting diverse audiences, and must not involve clinical trials. The program supports the development of novel instructional methods and educational resources aimed at advancing cancer research and education. Key dates include an application opening on December 25, 2023, and due dates for submissions. Review criteria include the significance of the proposed program, investigator qualifications, and the appropriateness of the proposed approach. Overall, this funding opportunity plays a crucial role in fostering a skilled workforce capable of addressing critical needs in cancer research and care.
    Similar Opportunities
    Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) to enhance education and training in cancer research. This program aims to support innovative educational activities that address various aspects of cancer, including its causes, prevention, treatment, and rehabilitation, with a focus on developing a skilled workforce to meet national biomedical research needs. Eligible applicants include a diverse range of institutions such as Historically Black Colleges and Universities, Hispanic-serving Institutions, and community-based organizations, with a maximum funding amount of $300,000 per year. Applications will be accepted starting December 25, 2023, with recurring deadlines until January 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)," aimed at enhancing the training of a workforce to meet the nation’s biomedical and clinical research needs, particularly in cancer research. This program seeks applications that propose innovative educational activities, specifically hands-on cancer research experiences lasting 8 to 15 weeks, complemented by additional educational initiatives. With a funding ceiling of $300,000 per year for a project period of up to five years, the program encourages participation from underrepresented groups and aims to provide unique educational opportunities not covered by existing programs. Interested applicants can find more information and guidelines at the NIH website, with the application deadline set for January 25, 2026.
    National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled the National Cancer Institute Youth Enjoy Science Research Education Program (R25), aimed at enhancing research education for students from diverse backgrounds, particularly those underrepresented in biomedical and behavioral sciences. This program supports educational activities that focus on providing research experiences, curriculum development, and outreach initiatives to engage middle and high school students, as well as undergraduates, in cancer research. The initiative is crucial for addressing disparities in cancer research representation and inspiring future generations in the field. Eligible applicants can receive up to $400,000 annually for a project period of up to five years, with applications due by September 28, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-026.html.
    NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the NCI Small Grants Program for Cancer Research (R03) for the years 2023 to 2025. This funding opportunity is designed to support small-scale research projects on cancer that can be completed within a two-year timeframe and with limited resources, including pilot studies, secondary data analyses, and the development of research methodologies or technologies. Grants of up to $50,000 per year are available to a wide range of eligible applicants, including higher education institutions, nonprofits, and various community organizations. Interested parties should submit their applications electronically via Grants.gov, with the first submission deadline having been January 22, 2023, and subsequent deadlines continuing through 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NCI Small Grants Program for Cancer Research (R03), aimed at supporting short-term cancer research projects that require limited resources. This funding opportunity encourages diverse research efforts, including pilot studies, secondary data analyses, and the development of research methodologies, with a maximum budget of $50,000 per year for projects lasting up to two years. The program is designed to address significant knowledge gaps in cancer research and is open to a wide range of applicants, including public, private, and foreign entities. Interested parties should note that the application period opens on January 24, 2025, with a submission deadline of February 24, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering a funding opportunity titled "NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)" aimed at supporting innovative preclinical and early-phase clinical research in cancer diagnosis, treatment, and prevention. This grant, with a funding ceiling of $275,000 over two years, encourages exploratory studies that may involve significant risk but have the potential to lead to breakthroughs in cancer research, particularly for underserved populations. Applications will be evaluated based on their significance, innovation, and rigor, with key deadlines for submission set for January 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for Research Education Programs (R25), aimed at enhancing training for the biomedical, behavioral, and clinical research workforce. This grant supports innovative educational activities focused on research skills development, with a funding ceiling of $150,000 per year for a maximum of five years, and is not intended for clinical trials. The initiative emphasizes the importance of creating accessible educational opportunities that foster diversity and collaboration among participants, ranging from upper undergraduates to faculty. Interested applicants can find more information and application guidelines at the provided link, with proposals due by May 25, 2025, and inquiries directed to grantsinfo@nih.gov.
    Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Exploratory Grants in Cancer Control through the R21 Clinical Trial Optional mechanism, aimed at advancing innovative research in cancer control. This funding opportunity encourages applications focused on behavioral modification, screening, and understanding the etiological factors of cancer, with the goal of developing novel methodologies and tools that can significantly impact population-based cancer research. Grants of up to $275,000 are available for projects lasting up to two years, with application deadlines beginning January 16, 2025, and continuing through 2028. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PA-25-253.html.
    Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research" (R21 Clinical Trial Not Allowed). This funding opportunity aims to enhance diversity among early-stage and junior investigators in cancer research, particularly from groups that are underrepresented in the biomedical, behavioral, clinical, and social sciences. The initiative encourages innovative studies in cancer biology, with a maximum funding amount of $275,000 available over a two-year period, and applications must demonstrate scientific merit and innovation. The application window opens on May 17, 2024, with the first awards expected to be made in June 2024; interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.